The National Institute of Allergy and Infectious Diseases (NIAID) is offering this grant to establish a Coordination and Data Sharing Center (CDSC) for the ReVAMPP Network, focused on developing vaccines and monoclonal antibodies for pandemic preparedness. This grant’s purpose is to support, coordinate, and manage ongoing and planned ReVAMPP activities. The CDSC will create a collaborative platform for data sharing, harmonizing reagents, assays, and animal models, and facilitating knowledge exchange on vaccine solutions and technology. It will also streamline communications, track network progress, and foster collaborations among Centers. Additionally, the CDSC will coordinate information exchange with NIAID, U.S. Government partners, and international organizations like WHO and CEPI, enhancing global pandemic readiness.
Opportunity ID: 346911
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-AI-23-021 |
Funding Opportunity Title: | Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network – Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 16, 2023 |
Last Updated Date: | Mar 16, 2023 |
Original Closing Date for Applications: | Jun 08, 2023 |
Current Closing Date for Applications: | Jun 08, 2023 |
Archive Date: | Jul 14, 2023 |
Estimated Total Program Funding: | – |
Award Ceiling: | $1,500,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Special district governments Public and State controlled institutions of higher education City or township governments Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Public housing authorities/Indian housing authorities Private institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) County governments Small businesses State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) solicits applications from single institutions or consortia of institutions to establish a Coordination and Data Sharing Center (CDSC) in support of the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers. Together, the CDSC and ReVAMPP Centers will form the ReVAMPP Network. The purpose of the CDSC is to support, coordinate, and manage ongoing and planned activities within the ReVAMPP Network. The CDSC is expected to establish and maintain a collaborative ReVAMPP Network platform for data sharing as needed to harmonize reagents, assays, animal models and exchange knowledge on structure/function-based vaccine solutions and antigen/immunogen design as well as assess the utility of vaccine technology platforms for virus families studied under the ReVAMPP Centers. The CDSC is also expected to facilitate effective communications across the ReVAMPP Centers by scheduling, and managing all meetings, tracking overall network progress and outputs, developing opportunities for collaboration among the Centers such as establishing working groups, and under the direction of NIAID, collating information and facilitating exchange with other NIAID/NIH programs, U.S. Government (USG)partners, and other key stakeholders, including the World Health Organization (WHO), Bill and Melinda Gates Foundation (BMGF), and Coalition for Epidemic Preparedness Innovations (CEPI) among others as appropriate. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-23-021.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 346911 Full Announcement-RFA-AI-23-021 -> RFA-AI-23-021-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00280597 | May 08, 2023 | Jun 08, 2023 | View |
Package 1
Mandatory forms
346911 RR_SF424_5_0-5.0.pdf
346911 PHS398_CoverPageSupplement_5_0-5.0.pdf
346911 RR_OtherProjectInfo_1_4-1.4.pdf
346911 PerformanceSite_4_0-4.0.pdf
346911 RR_KeyPersonExpanded_4_0-4.0.pdf
346911 RR_Budget_3_0-3.0.pdf
346911 PHS398_ResearchPlan_5_0-5.0.pdf
346911 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
346911 RR_SubawardBudget30_3_0-3.0.pdf
346911 PHS_AssignmentRequestForm_3_0-3.0.pdf